Switzerland first to pass European Commission's GMP equivalence test for drug APIs
This article was originally published in SRA
Executive Summary
Switzerland has become the first country to receive an "equivalence" rating from the European Commission for its regulatory framework on active pharmaceutical ingredients (APIs)1,2. This means that the country will not have to confirm in writing that individual consignments of Swiss-manufactured APIs imported into the EU match up to the latter's good manufacturing practice standards.